Immuno Oncology Assays Market Share was valued at USD 3,836 million in 2020 and is expected to register a CAGR of 12.8% during the forecast period.

Introduction of the Immuno Oncology Assays Market Report

Immuno Oncology assays refers to the usage of several immunology assays which are used for the monitoring of the interaction between the cancer cells and immune cells. The immune system of humans has a high potential to destroy tumor cells producing no toxicity to normal cells. The global immuno oncology assays market covers various products & services such as consumables, instruments, software, and services.

To have an edge over the competition by knowing the market dynamics and current trends of “Immuno Oncology Assays Market”, request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The major factors that are surging the growth of the global immuno oncology assays market size include the surging demand for personalized medicine, along with the growing incidences of cancer and the increasing adoption of targeted therapy. Cancer is a complex disease that is developed through the multi-stage carcinogenesis process, which includes various molecular pathway events. As per the GLOBOCAN, the total number of cancer cases is increasing and is expected to reach 30 million by the end of 2040, which was 18 million in 2018. Around 605 of the cancer cases are taking place in Asia, the U.S., and Africa. Therefore, the increasing prevalence of cancer is directly increasing the demand for immuno oncology assays.

Various emerging countries such as India, China, South Korea, and Brazil are further helping the market to grow over the coming years. These countries are largely focusing on increasing their healthcare expenditure which is creating new growth opportunities for the market. As per the WHO, the current health expenditure (% of GDP) in 2018 amounted to 5.3%, which was 5.1% in 2017.

Restraint in the Immuno Oncology Assays Market

On the other hand, the high capital investment required, and the low cost-benefit ratio are the two major factors that are hindering the growth of the immuno oncology assays market share.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Technology – Segment Analysis

Based on the technology, the PCR segment is expected to grow at a higher CAGR during the forecast period. This is mainly due to the increasing usage of PCR technology in immuno-oncology bio market identification and discovery research.

Product & Service – Segment Analysis

Based on the product & service, the reagents and antibodies segment is projected to grow at a faster CAGR during the forecast period. The rising incidences of several types of cancer around the globe is a major factor that is surging the segment growth. The rising number of cancer patients is mainly because of population growth and aging.  Cancer-related to lungs and female breasts are among the most common categories in the world.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

Based on the region, North America region is expected to dominate the market during the forecast period. The high prevalence of cancer in this region is a key driver that is propelling the market growth. As per the National Institutes of Health (NIH), in 2018, there were 1,735,350 new cases of cancer in the U.S., and 609,640 people died from the disease. On the other hand, the Asia-Pacific region is projected to grow at a higher CAGR during the forecast period. This is mainly attributed to the increasing support from government bodies and the high prevalence of cancer in Asian countries.

Top Market Players

Various notable players operating in the market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, Agilent Technologies, Inc., Abbott, Sartorius AG, Nanostring Technologies, Inc., HTG Molecular Diagnostics, Inc., and Perkinelmer, Inc., among others.

Segments covered in the Report:

The global Immuno Oncology Assays market has been segmented on the basis of Product & Service, Technology, Indication, Application and regions. Based on Product & Service, the market is segmented into Reagents and Antibodies, Instruments, Software, and Consumables and Accessories. Based on Technology, the market is segmented into Polymerase Chain Reaction, Immunoassay, Next-Generation Sequencing, In Situ Hybridization, And Flow Cytometry. Based on Indication, the market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Melanoma and Others. Based on Application the market is segmented into Research Applications and Clinical Diagnostic.

For detailed scope of the “Immuno Oncology Assays Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global Immuno Oncology Assays market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in Immuno Oncology Assays market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global Immuno Oncology Assays market?
  • Which Product & Service generated maximum revenues in 2019 and identify the most promising Product & Service during the forecast period?
  • What are the various Technology areas of global Immuno Oncology Assays market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Base Year	2019
Market Forecast Period	2020-2027
Market Revenues (2020)	USD 3,836 million
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Product & Service, By Technology, By Indication, By Application, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, Agilent Technologies, Inc., Abbott, Sartorius AG, Nanostring Technologies, Inc., HTG Molecular Diagnostics, Inc., and Perkinelmer, Inc., among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Immuno Oncology Assays Market by Product & Service

• • Reagents and Antibodies
  • Instruments
  • Software
  • Consumables and Accessories

Global Immuno Oncology Assays Market by Technology

• • Polymerase Chain Reaction
  • Immunoassay
  • Next-Generation Sequencing
  • In Situ Hybridization
  • Flow Cytometry

Global Immuno Oncology Assays Market by Indication

• • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Bladder Cancer
  • Melanoma
  • Others

Global Immuno Oncology Assays Market by Application

• • Research Applications
  • Clinical Diagnostic

Global Immuno Oncology Assays Market by Region

• • North America Immuno Oncology Assays Market (Option 1: As a part of the free 25% customization)
    • North America Immuno Oncology Assays Market by Product & Service
    • North America Immuno Oncology Assays Market by Technology
    • North America Immuno Oncology Assays Market by Indication
    • North America Immuno Oncology Assays Market by Application
    • US Immuno Oncology Assays Market All-Up
    • Canada Immuno Oncology Assays Market All-Up
  • Europe Immuno Oncology Assays Market (Option 2: As a part of the free 25% customization)
    • Europe Immuno Oncology Assays Market by Product & Service
    • Europe Immuno Oncology Assays Market by Technology
    • Europe Immuno Oncology Assays Market by Indication
    • Europe Immuno Oncology Assays Market by Application
    • UK Immuno Oncology Assays Market All-Up
    • Germany Immuno Oncology Assays Market All-Up
    • France Immuno Oncology Assays Market All-Up
    • Spain Immuno Oncology Assays Market All-Up
    • Rest of Europe Immuno Oncology Assays Market All-Up
  • Asia-Pacific Immuno Oncology Assays Market (Option 3: As a part of the free 25% customization)
    • Asia-Pacific Immuno Oncology Assays Market by Product & Service
    • Asia-Pacific Immuno Oncology Assays Market by Technology
    • Asia-Pacific Immuno Oncology Assays Market by Indication
    • Asia-Pacific Immuno Oncology Assays Market by Application
    • China Immuno Oncology Assays Market All-Up
    • India Immuno Oncology Assays Market All-Up
    • Japan Immuno Oncology Assays Market All-Up
    • Rest of APAC Immuno Oncology Assays Market All-Up
  • RoW Immuno Oncology Assays Market (Option 4: As a part of the free 25% customization)
    • RoW Immuno Oncology Assays Market by Product & Service
    • RoW Immuno Oncology Assays Market by Technology
    • RoW Immuno Oncology Assays Market by Indication
    • RoW Immuno Oncology Assays Market by Application
    • Brazil Immuno Oncology Assays Market All-Up
    • South Africa Immuno Oncology Assays Market All-Up
    • Saudi Arabia Immuno Oncology Assays Market All-Up
    • UAE Immuno Oncology Assays Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Immuno Oncology Assays Market All-Up

Major Players Operating in the Immuno Oncology Assays (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Abbott
  • Sartorius AG
  • Nanostring Technologies, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Perkinelmer, Inc.